skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 24  for All Library Resources

Results 1 2 next page
Refined by: subject: Osteoporosis remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Eldecalcitol is superior to alfacalcidol in maintaining bone mineral density in glucocorticoid-induced osteoporosis patients (e-GLORIA)
Material Type:
Article
Add to My Research

Eldecalcitol is superior to alfacalcidol in maintaining bone mineral density in glucocorticoid-induced osteoporosis patients (e-GLORIA)

Journal of bone and mineral metabolism, 2020-07, Vol.38 (4), p.522-532 [Peer Reviewed Journal]

The Japanese Society Bone and Mineral Research and Springer Japan KK, part of Springer Nature 2020 ;The Japanese Society Bone and Mineral Research and Springer Japan KK, part of Springer Nature 2020. ;ISSN: 0914-8779 ;EISSN: 1435-5604 ;DOI: 10.1007/s00774-020-01091-4 ;PMID: 32140784

Full text available

2
Osteocyte network; a negative regulatory system for bone mass augmented by the induction of Rankl in osteoblasts and Sost in osteocytes at unloading
Material Type:
Article
Add to My Research

Osteocyte network; a negative regulatory system for bone mass augmented by the induction of Rankl in osteoblasts and Sost in osteocytes at unloading

PloS one, 2012-06, Vol.7 (6), p.e40143-e40143 [Peer Reviewed Journal]

COPYRIGHT 2012 Public Library of Science ;COPYRIGHT 2012 Public Library of Science ;2012 Moriishi et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License: https://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Moriishi et al. 2012 ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0040143 ;PMID: 22768243

Full text available

3
Minodronate combined with alfacalcidol versus alfacalcidol alone for glucocorticoid-induced osteoporosis: a multicenter, randomized, comparative study
Material Type:
Article
Add to My Research

Minodronate combined with alfacalcidol versus alfacalcidol alone for glucocorticoid-induced osteoporosis: a multicenter, randomized, comparative study

Journal of bone and mineral metabolism, 2020-07, Vol.38 (4), p.511-521 [Peer Reviewed Journal]

The Japanese Society Bone and Mineral Research and Springer Japan KK, part of Springer Nature 2020 ;The Japanese Society Bone and Mineral Research and Springer Japan KK, part of Springer Nature 2020. ;ISSN: 0914-8779 ;EISSN: 1435-5604 ;DOI: 10.1007/s00774-019-01077-x ;PMID: 31970477

Full text available

4
Activation of Renin‐Angiotensin System Induces Osteoporosis Independently of Hypertension
Material Type:
Article
Add to My Research

Activation of Renin‐Angiotensin System Induces Osteoporosis Independently of Hypertension

Journal of bone and mineral research, 2009-02, Vol.24 (2), p.241-250 [Peer Reviewed Journal]

Copyright © 2009 ASBMR ;2009 INIST-CNRS ;ISSN: 0884-0431 ;EISSN: 1523-4681 ;DOI: 10.1359/jbmr.081006 ;PMID: 18847324 ;CODEN: JBMREJ

Full text available

5
Overexpression of Bcl2 in osteoblasts inhibits osteoblast differentiation and induces osteocyte apoptosis
Material Type:
Article
Add to My Research

Overexpression of Bcl2 in osteoblasts inhibits osteoblast differentiation and induces osteocyte apoptosis

PloS one, 2011-11, Vol.6 (11), p.e27487-e27487 [Peer Reviewed Journal]

COPYRIGHT 2011 Public Library of Science ;COPYRIGHT 2011 Public Library of Science ;2011 Moriishi et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License: https://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Moriishi et al. 2011 ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0027487 ;PMID: 22114675

Full text available

6
Monthly oral ibandronate 100 mg is as effective as monthly intravenous ibandronate 1 mg in patients with various pathologies in the MOVEST study
Material Type:
Article
Add to My Research

Monthly oral ibandronate 100 mg is as effective as monthly intravenous ibandronate 1 mg in patients with various pathologies in the MOVEST study

Journal of bone and mineral metabolism, 2018-05, Vol.36 (3), p.336-343 [Peer Reviewed Journal]

The Japanese Society for Bone and Mineral Research and Springer Japan 2017 ;Journal of Bone and Mineral Metabolism is a copyright of Springer, (2017). All Rights Reserved. ;ISSN: 0914-8779 ;EISSN: 1435-5604 ;DOI: 10.1007/s00774-017-0839-2 ;PMID: 28389932

Full text available

7
Once-weekly teriparatide reduces the risk of vertebral fracture in patients with various fracture risks: subgroup analysis of the Teriparatide Once-Weekly Efficacy Research (TOWER) trial
Material Type:
Article
Add to My Research

Once-weekly teriparatide reduces the risk of vertebral fracture in patients with various fracture risks: subgroup analysis of the Teriparatide Once-Weekly Efficacy Research (TOWER) trial

Journal of bone and mineral metabolism, 2014-07, Vol.32 (4), p.441-446 [Peer Reviewed Journal]

The Japanese Society for Bone and Mineral Research and Springer Japan 2013 ;The Japanese Society for Bone and Mineral Research and Springer Japan 2014 ;ISSN: 0914-8779 ;EISSN: 1435-5604 ;DOI: 10.1007/s00774-013-0505-2 ;PMID: 24213216

Full text available

8
Effect of minodronic acid hydrate on hip geometry in Japanese women with postmenopausal osteoporosis
Material Type:
Article
Add to My Research

Effect of minodronic acid hydrate on hip geometry in Japanese women with postmenopausal osteoporosis

Journal of bone and mineral metabolism, 2010-05, Vol.28 (3), p.334-341 [Peer Reviewed Journal]

The Japanese Society for Bone and Mineral Research and Springer 2009 ;2015 INIST-CNRS ;The Japanese Society for Bone and Mineral Research and Springer 2010 ;ISSN: 0914-8779 ;EISSN: 1435-5604 ;DOI: 10.1007/s00774-009-0138-7 ;PMID: 19937358

Full text available

9
Assessment of bone quality using micro-computed tomography (micro-CT) and synchrotron micro-CT
Material Type:
Article
Add to My Research

Assessment of bone quality using micro-computed tomography (micro-CT) and synchrotron micro-CT

Journal of bone and mineral metabolism, 2005, Vol.23 Suppl (S1), p.115-121 [Peer Reviewed Journal]

Springer-Verlag 2005 ;Springer-Verlag 2005. ;ISSN: 0914-8779 ;EISSN: 1435-5604 ;DOI: 10.1007/bf03026335 ;PMID: 15984426

Full text available

10
Effects of 3-year denosumab treatment on hip structure in Japanese postmenopausal women and men with osteoporosis
Material Type:
Article
Add to My Research

Effects of 3-year denosumab treatment on hip structure in Japanese postmenopausal women and men with osteoporosis

Bone Reports, 2017-12, Vol.7 (C), p.164-171 [Peer Reviewed Journal]

2017 The Authors 2017 ;ISSN: 2352-1872 ;EISSN: 2352-1872 ;DOI: 10.1016/j.bonr.2017.11.002 ;PMID: 29188222

Full text available

11
Bone structure and mineralization demonstrated using synchrotron radiation computed tomography (SR-CT) in animal models: preliminary findings
Material Type:
Article
Add to My Research

Bone structure and mineralization demonstrated using synchrotron radiation computed tomography (SR-CT) in animal models: preliminary findings

Journal of bone and mineral metabolism, 2003-01, Vol.21 (5), p.287-293 [Peer Reviewed Journal]

2004 INIST-CNRS ;Springer-Verlag Tokyo 2003 ;ISSN: 0914-8779 ;EISSN: 1435-5604 ;DOI: 10.1007/s00774-003-0422-x ;PMID: 12928829

Full text available

12
Effect and safety of intermittent weekly administration of human parathyroid hormone 1-34 in patients with primary osteoporosis evaluated by histomorphometry and microstructural analysis of iliac trabecular bone before and after 1 year of treatment
Material Type:
Article
Add to My Research

Effect and safety of intermittent weekly administration of human parathyroid hormone 1-34 in patients with primary osteoporosis evaluated by histomorphometry and microstructural analysis of iliac trabecular bone before and after 1 year of treatment

Journal of bone and mineral metabolism, 2004-11, Vol.22 (6), p.569-576 [Peer Reviewed Journal]

2004 INIST-CNRS ;Copyright 2004 Springer-Verlag ;Springer-Verlag Tokyo 2004 ;ISSN: 0914-8779 ;EISSN: 1435-5604 ;DOI: 10.1007/s00774-004-0525-z ;PMID: 15490267

Full text available

13
Which bone densitometry and which skeletal site are clinically useful for monitoring bone mass?
Material Type:
Article
Add to My Research

Which bone densitometry and which skeletal site are clinically useful for monitoring bone mass?

Osteoporosis international, 2003-12, Vol.14 (12), p.959-964 [Peer Reviewed Journal]

2004 INIST-CNRS ;International Osteoporosis Foundation and National Osteoporosis Foundation 2003 ;ISSN: 0937-941X ;EISSN: 1433-2965 ;DOI: 10.1007/s00198-003-1497-x ;PMID: 12955312

Full text available

14
Regulation of mineral-to-matrix ratio of lumbar trabecular bone in ovariectomized rats treated with risedronate in combination with or without vitamin K2
Material Type:
Article
Add to My Research

Regulation of mineral-to-matrix ratio of lumbar trabecular bone in ovariectomized rats treated with risedronate in combination with or without vitamin K2

Journal of bone and mineral metabolism, 2004, Vol.22 (5), p.404-414 [Peer Reviewed Journal]

2004 INIST-CNRS ;Springer-Verlag Tokyo 2004 ;ISSN: 0914-8779 ;EISSN: 1435-5604 ;DOI: 10.1007/s00774-004-0502-6 ;PMID: 15316861

Full text available

15
Human parathyroid hormone (1-34) increases mass and structure of the cortical shell, with resultant increase in lumbar bone strength, in ovariectomized rats
Material Type:
Article
Add to My Research

Human parathyroid hormone (1-34) increases mass and structure of the cortical shell, with resultant increase in lumbar bone strength, in ovariectomized rats

Journal of bone and mineral metabolism, 2004-11, Vol.22 (6), p.530-540 [Peer Reviewed Journal]

2004 INIST-CNRS ;Copyright 2004 Springer-Verlag ;Springer-Verlag Tokyo 2004 ;ISSN: 0914-8779 ;EISSN: 1435-5604 ;DOI: 10.1007/s00774-004-0520-4 ;PMID: 15490262

Full text available

16
Modulation of bone turnover by alfacalcidol and/or alendronate does not prevent glucocorticoid-induced osteoporosis in growing minipigs
Material Type:
Article
Add to My Research

Modulation of bone turnover by alfacalcidol and/or alendronate does not prevent glucocorticoid-induced osteoporosis in growing minipigs

Journal of bone and mineral metabolism, 2005-09, Vol.23 (5), p.341-350 [Peer Reviewed Journal]

2005 INIST-CNRS ;Springer-Verlag Tokyo 2005 ;ISSN: 0914-8779 ;EISSN: 1435-5604 ;DOI: 10.1007/s00774-005-0611-x ;PMID: 16133683

Full text available

17
CD109 deficiency induces osteopenia with an osteoporosis‐like phenotype in vivo
Material Type:
Article
Add to My Research

CD109 deficiency induces osteopenia with an osteoporosis‐like phenotype in vivo

Genes to cells : devoted to molecular & cellular mechanisms, 2018-07, Vol.23 (7), p.590-598 [Peer Reviewed Journal]

2018 Molecular Biology Society of Japan and John Wiley & Sons Australia, Ltd ;2018 Molecular Biology Society of Japan and John Wiley & Sons Australia, Ltd. ;Copyright © 2018 Molecular Biology Society of Japan and John Wiley & Sons Australia, Ltd ;ISSN: 1356-9597 ;EISSN: 1365-2443 ;DOI: 10.1111/gtc.12593 ;PMID: 29767469

Full text available

18
Clinical Efficacy on Fracture Risk and Safety of 0.5 mg or 1 mg/month Intravenous Ibandronate Versus 2.5 mg/day Oral Risedronate in Patients with Primary Osteoporosis
Material Type:
Article
Add to My Research

Clinical Efficacy on Fracture Risk and Safety of 0.5 mg or 1 mg/month Intravenous Ibandronate Versus 2.5 mg/day Oral Risedronate in Patients with Primary Osteoporosis

Calcified tissue international, 2013-08, Vol.93 (2), p.137-146 [Peer Reviewed Journal]

The Author(s) 2013 ;Springer Science+Business Media New York 2013 ;ISSN: 0171-967X ;EISSN: 1432-0827 ;DOI: 10.1007/s00223-013-9734-6 ;PMID: 23644930

Full text available

19
GPR98/Gpr98 Gene Is Involved in the Regulation of Human and Mouse Bone Mineral Density
Material Type:
Article
Add to My Research

GPR98/Gpr98 Gene Is Involved in the Regulation of Human and Mouse Bone Mineral Density

The journal of clinical endocrinology and metabolism, 2012-04, Vol.97 (4), p.E565-E574 [Peer Reviewed Journal]

Copyright © 2012 by The Endocrine Society ;ISSN: 0021-972X ;EISSN: 1945-7197 ;DOI: 10.1210/jc.2011-2393 ;PMID: 22419726

Full text available

20
24-Month Open-Label Teriparatide Once-Weekly Efficacy Research Trial Examining Bone Mineral Density in Subjects with Primary Osteoporosis and High Fracture Risk
Material Type:
Article
Add to My Research

24-Month Open-Label Teriparatide Once-Weekly Efficacy Research Trial Examining Bone Mineral Density in Subjects with Primary Osteoporosis and High Fracture Risk

Advances in therapy, 2017-07, Vol.34 (7), p.1727-1740 [Peer Reviewed Journal]

The Author(s) 2017 ;ISSN: 0741-238X ;EISSN: 1865-8652 ;DOI: 10.1007/s12325-017-0568-x

Digital Resources/Online E-Resources

Results 1 - 20 of 24  for All Library Resources

Results 1 2 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Refine My Results

Creation Date 

From To
  1. Before 2003  (3)
  2. 2003 To 2008  (7)
  3. 2009 To 2011  (3)
  4. 2012 To 2015  (6)
  5. After 2015  (6)
  6. More options open sub menu

Searching Remote Databases, Please Wait